Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.33)
# 4,063
Out of 4,832 analysts
24
Total ratings
26.67%
Success rate
-30.26%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $38.94 | +48.95% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $4.60 | +465.22% | 2 | Mar 13, 2025 | |
| ZYXI Zynex | Downgrades: Neutral | n/a | $2.10 | - | 2 | Mar 12, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $0.96 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $1.96 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $4.16 | +1,031.17% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $2.44 | +14,777.05% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.66 | +5,321.69% | 1 | Aug 4, 2022 | |
| HROW Harrow | Initiates: Buy | $14 | $25.13 | -43.28% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.26 | +455.56% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $5.61 | +826.92% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $551,250 | $0.87 | +63,361,968.97% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.68 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $58.62 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $38.94
Upside: +48.95%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $4.60
Upside: +465.22%
Zynex
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.10
Upside: -
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.96
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.96
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $4.16
Upside: +1,031.17%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $2.44
Upside: +14,777.05%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.66
Upside: +5,321.69%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $25.13
Upside: -43.28%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.26
Upside: +455.56%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $5.61
Upside: +826.92%
Jun 26, 2020
Initiates: Buy
Price Target: $551,250
Current: $0.87
Upside: +63,361,968.97%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $5.68
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $58.62
Upside: -